Clinical and cost‐effectiveness of earlier discharge from acute hospital after total joint arthroplasty

Siddharth Rele,Chris Schilling,Cade Shadbolt,Tim Spelman,Nicholas F Taylor,Michelle M Dowsey,Peter FM Choong
DOI: https://doi.org/10.1111/ans.19322
IF: 1.7
2024-12-08
ANZ Journal of Surgery
Abstract:Earlier discharge by 1 day after total joint arthroplasty was safe. However, an increase in odds of discharge to inpatient rehabilitation offset cost savings associated with earlier discharge. Background Reducing length of stay has been proposed as a key component of policies that aim to meet demand and minimize costs associated with total joint arthroplasty. However, few studies explore shifting of healthcare utilization when length of stay is shortened. Methods This retrospective cohort study examined patients undergoing primary, total hip and knee arthroplasty for osteoarthritis to simulate a policy‐level institutional reduction in acute hospital stay by 1 day. Costs, quality of life, and rates of complications, readmission and discharge to inpatient rehabilitation were compared in patients with a three‐ and four‐day length of acute stay. Balance was achieved using overlap‐propensity weighting. Results In total, 2023 patients were included. Earlier discharge from acute hospital was not associated with a change in odds of 90‐day complications (OR: 0.85 [95% CI, 0.58 to 1.27]; P = 0.447), readmissions (OR: 1.11 [95% CI, 0.67 to 1.82]; P = 0.691), and emergency department presentations (OR: 1.07 [95% CI, 0.66 to 1.73]; P = 0.774). Earlier discharge from acute hospital was associated with an increase in odds of discharge to inpatient rehabilitation (OR: 2.16 [95% CI, 1.45 to 3.20]; P
surgery
What problem does this paper attempt to address?